- Home
- Medical
- Pharmacology
- Quantitative Drug Safety and Benefit Risk Evaluation (Practical and Cross-Disciplinary Approaches)
Quantitative Drug Safety and Benefit Risk Evaluation (Practical and Cross-Disciplinary Approaches)
List Price:
$72.99
- Availability: Confirm prior to ordering
- Branding: minimum 50 pieces (add’l costs below)
- Check Freight Rates (branded products only)
Branding Options (v), Availability & Lead Times
- 1-Color Imprint: $2.00 ea.
- Promo-Page Insert: $2.50 ea. (full-color printed, single-sided page)
- Belly-Band Wrap: $2.50 ea. (full-color printed)
- Set-Up Charge: $45 per decoration
- Availability: Product availability changes daily, so please confirm your quantity is available prior to placing an order.
- Branded Products: allow 10 business days from proof approval for production. Branding options may be limited or unavailable based on product design or cover artwork.
- Unbranded Products: allow 3-5 business days for shipping. All Unbranded items receive FREE ground shipping in the US. Inquire for international shipping.
- RETURNS/CANCELLATIONS: All orders, branded or unbranded, are NON-CANCELLABLE and NON-RETURNABLE once a purchase order has been received.
Product Details
Author:
William Wang, Melvin Munsaka, James Buchanan, Judy Li
Format:
Paperback
Pages:
402
Publisher:
CRC Press (January 29, 2024)
Language:
English
ISBN-13:
9781032191119
Dimensions:
6.125" x 9.1875"
File:
TAYLORFRANCIS-TayFran_260513043736269-20260513.xml
Folder:
TAYLORFRANCIS
List Price:
$72.99
Series:
Chapman & Hall/CRC Biostatistics Series
As low as:
$69.34
Publisher Identifier:
P-CRC
Discount Code:
H
Country of Origin:
United States
Weight:
29.75oz
Case Pack:
1
Pub Discount:
30
Imprint:
Chapman and Hall/CRC
Overview
Quantitative Methodologies and Process for Safety Monitoring and Ongoing Benefit Risk Evaluation provides a comprehensive coverage on safety monitoring methodologies, covering both global trends and regional initiatives. Pharmacovigilance has traditionally focused on the handling of individual adverse event reports however recently there had been a shift towards aggregate analysis to better understand the scope of product risks.
Written to be accessible not only to statisticians but also to safety scientists with a quantitative interest, this book aims to bridge the gap in knowledge between medical and statistical fields creating a truly multi-disciplinary approach that is very much needed for 21st century safety evaluation.
